Teva Pharmaceutical Industries Limited (FRA:TEV)
27.80
+1.10 (4.12%)
At close: Jan 29, 2026
FRA:TEV Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 3,556 | 3,300 | 3,226 | 2,801 | 2,165 |
Cash & Short-Term Investments | 3,556 | 3,300 | 3,226 | 2,801 | 2,165 |
Cash Growth | 7.76% | 2.29% | 15.17% | 29.38% | -0.55% |
Receivables | 3,709 | 3,059 | 3,408 | 3,696 | 4,529 |
Inventory | 3,179 | 3,007 | 4,021 | 3,833 | 3,818 |
Prepaid Expenses | 1,122 | 1,006 | 1,255 | 1,162 | 1,075 |
Restricted Cash | - | - | 1 | 33 | 33 |
Other Current Assets | 2,380 | 2,180 | 574 | 526 | 953 |
Total Current Assets | 13,946 | 12,552 | 12,485 | 12,051 | 12,573 |
Property, Plant & Equipment | 4,425 | 4,948 | 6,147 | 6,158 | 6,477 |
Long-Term Investments | - | - | 8 | - | - |
Goodwill | 16,000 | 15,147 | 17,177 | 17,633 | 20,040 |
Other Intangible Assets | 3,781 | 4,418 | 5,387 | 6,270 | 7,466 |
Long-Term Deferred Tax Assets | 2,191 | 1,799 | 1,812 | 1,458 | 596 |
Other Long-Term Assets | 405 | 462 | 463 | 441 | 514 |
Total Assets | 40,748 | 39,326 | 43,479 | 44,011 | 47,666 |
Accounts Payable | 2,531 | 2,203 | 2,602 | 1,887 | 1,686 |
Accrued Expenses | 3,426 | 5,651 | 5,525 | 4,955 | 5,280 |
Short-Term Debt | 1,820 | - | - | - | - |
Current Portion of Long-Term Debt | - | 1,781 | 1,672 | 2,109 | 1,426 |
Current Portion of Leases | - | 87 | 97 | 93 | 109 |
Other Current Liabilities | 5,679 | 3,074 | 2,351 | 2,425 | 2,526 |
Total Current Liabilities | 13,456 | 12,796 | 12,247 | 11,469 | 11,027 |
Long-Term Debt | 14,986 | 16,002 | 18,161 | 19,103 | 21,617 |
Long-Term Leases | 288 | 314 | 343 | 371 | 441 |
Pension & Post-Retirement Benefits | - | 63 | 73 | - | - |
Long-Term Deferred Tax Liabilities | 296 | 483 | 606 | 548 | 784 |
Other Long-Term Liabilities | 3,808 | 3,948 | 3,923 | 3,922 | 2,553 |
Total Liabilities | 32,834 | 33,606 | 35,353 | 35,413 | 36,422 |
Common Stock | 7,910 | 58 | 57 | 57 | 57 |
Additional Paid-In Capital | - | 27,764 | 27,807 | 27,688 | 27,561 |
Retained Earnings | - | -15,173 | -13,534 | -12,975 | -10,529 |
Treasury Stock | - | -4,128 | -4,128 | -4,128 | -4,128 |
Comprehensive Income & Other | - | -3,148 | -2,696 | -2,838 | -2,683 |
Total Common Equity | 7,910 | 5,373 | 7,506 | 7,804 | 10,278 |
Minority Interest | 4 | 347 | 620 | 794 | 966 |
Shareholders' Equity | 7,914 | 5,720 | 8,126 | 8,598 | 11,244 |
Total Liabilities & Equity | 40,748 | 39,326 | 43,479 | 44,011 | 47,666 |
Total Debt | 17,094 | 18,184 | 20,273 | 21,676 | 23,593 |
Net Cash (Debt) | -13,538 | -14,884 | -17,047 | -18,875 | -21,428 |
Net Cash Per Share | -11.64 | -13.16 | -15.23 | -17.00 | -19.36 |
Filing Date Shares Outstanding | 1,149 | 1,134 | 1,121 | 1,111 | 1,103 |
Total Common Shares Outstanding | 1,149 | 1,134 | 1,121 | 1,111 | 1,103 |
Working Capital | 490 | -244 | 238 | 582 | 1,546 |
Book Value Per Share | 6.88 | 4.74 | 6.70 | 7.02 | 9.32 |
Tangible Book Value | -11,871 | -14,192 | -15,058 | -16,099 | -17,228 |
Tangible Book Value Per Share | -10.33 | -12.52 | -13.43 | -14.49 | -15.61 |
Land | - | 213 | 246 | 246 | 262 |
Buildings | - | 1,968 | 2,488 | 2,463 | 2,568 |
Machinery | - | 5,480 | 7,226 | 7,349 | 7,359 |
Construction In Progress | - | 1,330 | 1,427 | 1,199 | 1,034 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.